Home Blog Page 433

PlanetWatch Raises 3M€ to Boost Business Development

By
NT Editor
-
0
PlanetWatch Raises 3M€ to Boost Business Development
The CERN spin-off, building the first global decentralized air quality monitoring network, has raised 3M€ at a challenging time for blockchain companies

SAINT-GENIS-POUILLY, France, January 26, 2023 (Newswire.com) - PlanetWatch raised a total of three million euros via a Simple Agreement for Future Equity (SAFE) complemented by bank loans. The CERN spin-off will use the capital to solidify the business' foundations and prepare for a larger Series A round later this year.

With a strong roadmap for 2023 that includes smart contracts for air quality data sales and the transition to a Web3 business model, PlanetWatch will use the funds towards three main purposes: strengthening the technical infrastructure, growing the air quality monitoring network, and boosting business development initiatives.

"We are honored that key entities from the Algorand ecosystem, as well as major French banks, continue to support PlanetWatch development," said Claudio Parrinello, co-founder and CEO of PlanetWatch. "At a challenging time for blockchain companies, PlanetWatch is being endorsed as a real-world blockchain project with a compelling use case and capable of closing business deals both with companies and governmental entities."

The round, bridging between a Seed one and a future Series A, was led by Borderless Capital. Additional investors include Algorand Inc. and the Algorand Foundation. Two French banks are providing additional liquidity via loans.

"In the framework of our $10M PLANETS.Fund, which is one of the largest air quality sensor runners in the PlanetWatch network, we are excited to lead this new financing round and back the company vision of building the largest decentralized global air quality monitoring network and use blockchain as the core tech to make it happen. We strongly believe that PlanetWatch can really disrupt and transform the air and green data economy and markets at a global scale," said David Garcia, CEO and Managing Partner at Borderless Capital 

"It is central to our mission to support solutions that use the Algorand blockchain to address environmental challenges," said Matt Keller, Head of Impact at the Algorand Foundation. "With its affordable air quality sensors, PlanetWatch empowers people to become agents of change in their own communities which in turn - among other things - gives policymakers real-time data to help combat air pollution on a localized level. In 2022, they became the largest project on Algorand in terms of daily number of transactions, proving that the real-world utility and potential for broad impact is there. We're excited to support the team in delivering on the roadmap ahead."

About PlanetWatch

PlanetWatch is a high-tech startup based in France that's leveraging the Algorand blockchain, advanced algorithms, and high-performance yet affordable air quality sensors, to deploy dense, low-cost air quality monitoring networks. The PlanetWatch network, which has over 20,000 sensors currently active worldwide, powers advanced data products both for governmental and private sector entities, while building the first global immutable air quality data ledger. An official CERN spin-off company, PlanetWatch is also a member of the Crypto Sustainability Coalition fostered by the World Economic Forum. 

Contact Information:
Beatriz Giestas
Communications Manager
[email protected]

João Simões de Abreu
Marketing Manager
[email protected]


Original Source: PlanetWatch Raises 3M€ to Boost Business Development

Smile Digital Health Closes $30 Million in Series B Funding to Progress Innovation as World-Leading Health Data Fabric

By
NT Editor
-
0
Smile Digital Health Closes Million in Series B Funding to Progress Innovation as World-Leading Health Data Fabric
The increasing need for interoperability in healthcare has driven significant growth and demand for the company's data fabric platform and continued innovation in this area.

TORONTO, January 26, 2023 (Newswire.com) - Smile CDR Inc. (doing business as Smile Digital Health) ("Smile"), a leading FHIR® health data fabric (HDF) and exchange solutions provider, announced the closing of approximately $30 million in Series B growth capital led by existing investors including UPMC Enterprises. 

Smile's HDF platform uses industry-leading HDF architecture and ONC-compliant, event-driven FHIR APIs to allow healthcare providers, payers and IT vendors to build secure, composable and scalable data infrastructures. Smile offers a suite of health data, clinical reasoning and marketplace utilities that can support ecosystem-wide data innovation and digital modernization efforts to accelerate healthcare innovation, improve quality of patient care journeys, boost operational efficiencies and reduce costs using intelligent automation implementation strategies.

"Our vision for better global health becomes more achievable when we focus on the inherent value of finding innovative ways to efficiently share and use data. Smile Digital Health has seen significant growth in our platform because it does just this. With transformative solutions that can meet companies' specific needs, we are preparing healthcare providers, payers, researchers and life sciences organizations for a connected future that transcends the capabilities of today's systems," said Duncan Weatherston, Chief Executive Officer at Smile Digital Health. 

Smile Digital Health is committed to continuing its advancements in end-to-end interoperability with expanded offerings that enhance the breadth of its data fabric solutions for future digital transformations. The company will use this new round of funding to expand its newly acquired clinical reasoning utility and forward-looking artificial intelligence and machine learning capabilities, further advancing Smile Digital Health as the leader in the field.

"Data fabrics open up many new ways of leveraging and working with health data. We will continue to delve into creating solutions that drive change in healthcare and enable better outcomes for everyone. We will also optimize our solutions, as new regulations and mandates are passed, consistently maintaining offerings that keep payers and providers compliant. When new innovations emerge in the industry, we will look at ways to leverage those in the HDF platform and through our add-on solutions to drive value through data," said Weatherston.

"Successfully raising $30 million in such a challenging capital markets environment is a testament to the strength and desirability of Smile's technological offering and the broad appeal of the vision of its founders," commented Smile Digital Health Chairman, George Rizk.

In 2022, Smile was cited by The Globe and Mail's ranking of Canada's Top Growing Companies. It was also recognized as a 2022 Deloitte Technology Fast 50™ and North America Technology Fast 500™ company for the second year running.

"Smile is a leader in the Health Data Fabric space and is a highly innovative and client-focused company looking to improve healthcare through access to digital information. Its work with Astrata, a company created by UPMC Enterprises, demonstrates Smile's ability to deliver value to many parties in the health ecosystem," said Brent Burns, Executive Vice President at UPMC Enterprises, the venture capital and commercialization arm of leading health system UPMC. "UPMC shares the same passion as Smile for improving healthcare via innovation."

Smile Digital Health has grown rapidly from a 2016 start-up to being a recognized leader in the digital health solutions space, servicing clients across the healthcare spectrum, including many top tier payers and providers across the United States and 18 other countries, as well as research institutions, other health information technology companies and government agencies. 

Smile's legal advisors in conjunction with this financing were Davies Ward Phillips & Vineberg LLP.

###

About Smile Digital Health

Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, open framework data fabric and integration platform fuels healthcare's digital transformation and accelerates value creation across all patient journeys at scale. Powered by our HL7® FHIR® standard-based clinical data repository (#SmileInside), our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate and meaningfully share the health information to power digital transformation. We prepare healthcare providers, payers, researchers and life sciences organizations for a connected future beyond legacy systems, adding new value through intelligent use of information and ultimately delivering better patient outcomes. For more information, visit: SmileDigitalHealth.com. 

Contact Information:
Victoria Valladolid
Acting Director of Marketing
[email protected]
(877) 537-3343 x 728


Original Source: Smile Digital Health Closes $30 Million in Series B Funding to Progress Innovation as World-Leading Health Data Fabric

Fragrance Creators Launches First of Its Kind Data Insights Program for Superior Forecasting of Emerging Public Policy, Regulatory, and Consumer & Marketplace Trends

By
NT Editor
-
0
Fragrance Creators Launches First of Its Kind Data Insights Program for Superior Forecasting of Emerging Public Policy, Regulatory, and Consumer & Marketplace Trends
The association will bolster its predictive capabilities, empowering stronger consensus building and industry stewardship; names Katie Cross Head of Programs Management & Policy Insights.

WASHINGTON, January 26, 2023 (Newswire.com) - The Fragrance Creators Association (Fragrance Creators) today announced the launch of a new data insights program designed to track, monitor and harvest disparate data points, news, scientific developments, and other information from around the globe with the goal of unmatched forecasting of public policy, regulatory, and consumer and marketplace trends. This will be a unique membership offering and empower the association to drive appropriate collective industry action and shape outcomes more proactively.

"To achieve our goal of serving consumers better, faster and more completely than ever before, Fragrance Creators must lead the way in predicting the trends, issues, opportunities and threats impacting perfume, people and the planet well into the future," said Farah K. Ahmed, Fragrance Creators President & CEO. "This program will deliver actionable insights that allow our members to see what's coming around the corner sooner and with sharper accuracy. It will also facilitate membership consensus building and preparedness so our companies can take the individual and collective actions necessary to deliver on our stewardship commitment."

"This is one more way Fragrance Creators is continuing to deliver greater value for our members," said Cynthia Reichard, Fragrance Creators Co-Chair and Executive Vice President of Arylessence. "In a competitive marketplace, having access to unique insights from a one-of-a-kind program like this is a distinct business advantage."

"As a scientist, I value data-backed insights, and that is no different when it comes to predicting emerging public policy trends, regulatory trends, or other trends impacting business," said Bob Weinstein, Ph.D., Fragrance Creators Co-Chair and CEO of Robertet US. "This new program gives me greater confidence in policy forecasting, and I look forward to harnessing these insights in both my industry and corporate leadership roles."

Katie Cross, current Fragrance Creators Director of Government Affairs, has been named to oversee the new analytics program, with the new title of Head of Programs Management & Policy Insights. During her tenure at Fragrance Creators, Cross has revamped the association's predictive and tracking capabilities in the legislative realm - providing members with unique insights, analysis and information, often before they hear it from anywhere else. Cross' new role will scale and grow those skills across the organization to empower the fragrance industry to deliver more good for people, perfume, and the planet.

"Katie's proven track record in strategic monitoring, analysis, and intelligence gathering, along with her project management skills, make her uniquely qualified to head this effort," concluded Ahmed.

###

About Fragrance Creators: Fragrance Creators Association is the trade association representing the majority of fragrance manufacturing in North America. We also represent fragrance-related interests along the value chain. Fragrance Creators' 60+ member companies are diverse, including large, medium, and small-sized companies that create, manufacture, and use fragrances and scents for home care, personal care, home design, fine fragrance, and industrial and institutional products, as well as those that supply fragrance ingredients, including natural extracts and other raw materials that are used in perfumery and fragrance mixtures. Fragrance Creators established and administers the Congressional Fragrance Caucus, ensuring ongoing dialogue with members of Congress and staff. We are an active participant in IFRA and have a designated representative on the IFRA Board to help ensure the association's membership is represented in global discussions and the North American perspective is considered in global fragrance positions and policies. Fragrance Creators also produces The Fragrance Conservatory, the comprehensive digital resource for high-quality information about fragrance—www.fragranceconservatory.com. Learn more about Fragrance Creators at fragrancecreators.org—for people, perfume, and the planet.

Contact Information:
Katie Cross
[email protected]


Original Source: Fragrance Creators Launches First of Its Kind Data Insights Program for Superior Forecasting of Emerging Public Policy, Regulatory, and Consumer & Marketplace Trends

ZetrOZ Systems to Showcase New Soft Tissue Healing Innovations sam®x1 and sam®2.0 Technologies at Regenerative and Musculoskeletal Ultrasound Course

By
NT Editor
-
0
ZetrOZ Systems to Showcase New Soft Tissue Healing Innovations sam®x1 and sam®2.0 Technologies at Regenerative and Musculoskeletal Ultrasound Course
Creator of wearable sustained acoustic medicine technology to educate clinicians on device's effectiveness in soft tissue healing and regenerative medicine treatment.


sam\u00aex1
sam\u00aex1

LAS VEGAS, January 26, 2023 (Newswire.com) - ZetrOZ Systems will demonstrate the effectiveness of its sam®x1 and sam®2.0 sustained acoustic medicine devices for soft tissue injury therapies at the Las Vegas Regenerative Medicine and MSK Ultrasound Course, the longest-running medical education seminar of its kind, from Jan. 26 to 28 in Las Vegas.

The sam®x1 is the first FDA-cleared pain management device of its kind cleared for everyday, at-home use, and the sam®2.0 is the long-duration solution. Both are wearable pain relief ultrasound devices that inhibit inflammation and accelerate natural healing by stimulating tissue regeneration, increasing circulation, and nutrient exchange in deep musculoskeletal tissue.

The multiple-day educational course, at the Planet Hollywood Resort and Casino, Las Vegas, welcomes hundreds of practitioners as varied as orthopedic surgeons, sports medicine physicians, PM&R physicians, pain management physicians, interventional radiologists, rheumatologists, physical therapists, naturopathic doctors, chiropractors, podiatrists, physician assistants, nurse practitioners, diagnostic sonographers and more.

"The Las Vegas Regenerative Medicine and MSK Ultrasound Course brings in leading physicians and other practitioners who will speak on the administration of ultrasound technology and its many benefits - it offers patients options beyond pain medication or surgery," says Dr. George Lewis, founder and CEO of ZetrOZ Systems. "We're incredibly excited to attend and bring awareness of our innovative pain relief ultrasound device portfolio to more healthcare professionals."

The first day of the program will be dedicated to reviewing scientific updates, new regulations, and best practices of the orthopedic discipline. The last two days will focus on practical ultrasound operation, and ZetrOZ Systems sam®x1 and sam®2.0 will be joining the lineup of medical treatment options available for clinicians to review and apply.

Backed by more than 30 clinical studies, sam® technology was developed with research funded by the National Institutes of Health and the U.S. Department of Defense with the intent of finding new methods of soft tissue healing that reduce the use of narcotics and invasive treatments.

To learn more about sustained acoustic medicine and its effectiveness in soft tissue healing, visit zetroz.com.

About ZetrOZ Systems

ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of +46 patents. The exclusive manufacturer and developer of the sam® product line is designed for the treatment of acute and chronic musculoskeletal conditions.

Contact Information:
Buse Kayar
[email protected]


Original Source: ZetrOZ Systems to Showcase New Soft Tissue Healing Innovations sam®x1 and sam®2.0 Technologies at Regenerative and Musculoskeletal Ultrasound Course

Pediatric Resources for Sexual Abuse Prevention Launched by The Mama Bear Effect

By
NT Editor
-
0
Pediatric Resources for Sexual Abuse Prevention Launched by The Mama Bear Effect
Call for pediatric involvement in primary prevention to address sexual victimization of children. Over 90% of parents agree that pediatricians should be discussing sexual abuse prevention with the families they serve.

BOSTON, January 26, 2023 (Newswire.com) - In response to the critical need of the medical and pediatric community for sexual abuse prevention resources, The Mama Bear Effect charitable organization announced, after over a year of development, free Pediatric Kits are now available for pediatricians and medical centers serving children to help educate medical professionals, parents, and children. 

"Child sexual abuse is an epidemic, with a conservative estimate of 10% of children at risk of abuse to potentially as many as 25% of girls and 16% of boys. Parents and caregivers want their pediatricians to educate them on sexual abuse prevention. We know this through the results of the recently published 2023 Parental and Caregiver Perspectives on Child Sexual Abuse Prevention study conducted with parents across the country. However, only 10% of pediatricians and family practitioners are estimated to be raising awareness about this epidemic with families, putting children at increased risk for abuse and a myriad of health consequences," said Adrianne Simeone, founder of The Mama Bear Effect.

Support from Pediatric Community 

Each Pediatric Kit includes a Pediatric Best Practices Guide, co-written with Dr. Martin Finkel, Professor Emeritus of the CARES Center at the Rowan-Virtua School of Osteopathic Medicine. 

As the founding co-director of the Child Abuse Research Education Services Institute and dedicating 40 years of my career to the issues of child sexual abuse," Dr. Finkel maintains, "it is clear that pediatricians and medical professionals serve a critical role in educating families to help prevent sexual abuse. We cannot effectively improve children's outcomes without addressing the risk of sexual abuse." 

National Support

Funding for the pediatric kits was supported in part by Indianapolis-based nonprofit kNot Today, founded by Linda and Frank Reich. "We are elated with the work of their Pediatric Best Practice Guide and look forward to sharing resources here in Indiana and beyond. Starting the conversations with parents and giving them resources are key to protecting children," shared Alyssa Van Vactor, Executive Director of kNot Today. 

Pediatric Kit Availability

Pediatric Kits are available for order through The Mama Bear Effect site: www.TheMamaBearEffect.org/pediatrics. If a medical center wishes to receive a free kit, they are invited to schedule a short meeting to discuss the survey participation required for the donation.

Founded in 2012, The Mama Bear Effect is a nationally recognized leader in child sexual abuse prevention education, partnering with child and family agencies across the country. A wide range of resources are available at TheMamaBearEffect.org, as well as a best-selling children's body safety book, My Body is Special and Private, on Amazon, and other printed educational materials for purchase. 

Contact Information:
Adrianne Simeone
President, The Mama Bear Effect
[email protected]
6175716802


Related Files
MBE_RESEARCH_REPORT_FINAL.pdf
PEDIATRIC BEST PRACTICES_REV2.pdf



Original Source: Pediatric Resources for Sexual Abuse Prevention Launched by The Mama Bear Effect

Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications

By
NT Editor
-
0
Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications

SARATOGA SPRINGS, N.Y., January 26, 2023 (Newswire.com) - Criterium, Inc., a full-service Contract Research Organization (CRO), is pleased to announce AURIC (Academic Urology Research Investigators Consortium) — a newly formed GU Oncology Consortium. The newest oncology consortia created by Criterium, Inc., it was launched in late July to support advanced oncology clinical research initiatives in translational research for genito-urinary (GU) cancers. This is the 5th specialty oncology consortia managed by Criterium. AURIC will follow in the footsteps of Criterium's other successful Consortia: in GI, Academic GI Cancer Consortium (AGICC); in breast, Academic Breast Cancer Consortium (ABRCC); in thoracic/lung cancers, Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC); and in multiple myeloma, Academic Myeloma Cancer Consortium (AMyC). These consortia are currently comprised of 41 renowned institutions and 73 Key Opinion Leaders in North America.

Directing the new consortium will be Dr. Thomas Flaig, Vice Chancellor of Research for the University of Colorado in Denver at the Anschutz Medical Campus. Dr. Flaig brings his significant clinical and translational research experience to this leadership position, having led both local and national multi-center clinical trials and served as the local principal investigator on a large number of Phase I, II and III studies. He previously served as medical director of the clinical trials office and associate director of clinical research at the CU Cancer Center. Known nationally for his work on bladder cancer, Dr. Flaig has been a member of the National Cancer Institute's Investigational Drug Steering Committee and the bladder cancer task force. He also serves as chair of the bladder cancer committee for the National Comprehensive Care Network. He is excited about the prospect of completing unique and forward-thinking trials from pharmaceutical companies investigating GU indications. His expertise and unique vision for research in the GU indications will create new possibilities for GU therapies and clinical studies that demonstrate important value for pharmaceutical sponsors and the patients who participate in these important trials.

About Criterium Inc.
Criterium is a full-service, global and technology-driven contract research organization that offers a unique mix of high-quality, innovative clinical research solutions for the biopharmaceutical, pharmaceutical, medical device and CRO industries. Visit us online: https://www.criteriuminc.com/  

About the Oncology Consortia of Criterium (OCC)
The Oncology Consortia of Criterium are a collaboration of outstanding Cancer Research Consortia delivering innovative research and unparalleled expertise. The Consortia Model utilizes translational science methodologies to streamline cancer research and development. Each member is usually located at a hospital or research center associated with an academic institution that has superior infrastructure and staff to meet the requirements — not only for translational and investigator-initiated studies, but also design and completion of all phases of clinical trials. Our model allows us to provide expertise and innovative solutions for the rapid design, implementation, and management of complex cancer trials. Visit the Consortia: https://www.criteriuminc.com/oncology-consortia/

Contact Information:
Claire Wynters
Marketing Manager
[email protected]
321-525-1285


Original Source: Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications

SpendMend Achieves Record Growth and Strategic Investments in 2022

By
NT Editor
-
0
SpendMend Achieves Record Growth and Strategic Investments in 2022
SpendMend sets company growth records in 2022 while receiving multiple strategic investments and completing multiple acquisitions.


SpendMend
SpendMend

GRAND RAPIDS, Mich., January 26, 2023 (Newswire.com) - SpendMend, a leading provider of cost-saving solutions for the healthcare industry, today announced record earnings in 2022, marking their fourth consecutive year of over 30% revenue growth. The company saw a 20% increase in employee count and a healthy increase in clients to over 150 major U.S. health systems, comprising over 3,000 hospitals and facilities. Clients also shared in the good news, enjoying a 32% increase in hard dollar savings delivered to their bottom line as compared to the previous year.

In addition to the strong growth indicators, SpendMend completed several major deals throughout the calendar year of 2022. The company secured a controlling investment from Morgan Stanley Capital Partners ("MSCP"), joined by additional investments from Corewell/Spectrum Health Ventures and Memorial Hermann Health System. 

"For several years, SpendMend has been establishing a new critical segment for the healthcare industry, the Cost-Cycle," states Steve Rodgers, Managing Director and Head of Healthcare at MSCP. "In 2022, we saw accelerated adoption in this growing segment; hospitals and health systems are using SpendMend's emerging cost-cycle platform as an effective strategy to drive significant bottom-line revenue and cost-savings while managing through pricing pressure, supply chain delays, and other lingering effects of the pandemic."

SpendMend, in the past year, expanded its cost-cycle platform through the acquisition of three leading healthcare providers including: VIE Healthcare Consulting, a leading cost consultant for hospitals; Trulla, a next-generation pharmacy procurement platform; and finally, the healthcare division of Moody Associates, P.A., a provider of profit recovery and contract-compliance services. 

Through their innovative suite of cost-cycle solutions, SpendMend helped U.S. healthcare networks to illuminate the "dark data" in their cost-cycle, unlocking trapped dollars and improving operations and overall efficiency. 

"Controlling costs is arguably the biggest challenge facing health systems across the country today," said Scott McLean, Managing Director at Corewell/Spectrum Health Ventures. "Simply put, SpendMend's suite of cost-cycle solutions helps hospitals reduce costs and optimize future savings. SpendMend is a perfect fit for the Corewell/Spectrum portfolio, and they are fast becoming an indispensable partner for U.S. Health Systems."

"For years, we have been guided by a mission to positively impact patient care by delivering value to our clients through our innovative cost-saving solutions," states SpendMend founder and CEO, Dan Geelhoed. "Through that lens, I believe our biggest success from the past year was watching our clients invest the bottom-line benefits of our work back into their patient communities."

About SpendMend 

SpendMend is the leading provider of tech-enabled, cost-savings solutions in the healthcare industry. By combining data, proprietary technology, and analytics with healthcare expertise, SpendMend partners with healthcare networks to expose and improve hidden costs in meaningful ways. The company's mission is to help its clients improve patient care through innovative cost-saving solutions.

Contact Information:
Kylee Savage
Marketing Manager
[email protected]
616-257-8331


Original Source: SpendMend Achieves Record Growth and Strategic Investments in 2022

AIMS 2.0 Uses RFID to Bring Next-Day Eyewear Delivery to Independent Eye Doctors

By
NT Editor
-
0
AIMS 2.0 Uses RFID to Bring Next-Day Eyewear Delivery to Independent Eye Doctors
Frame Source and SimplyRFiD partner to bring eyewear order management to independent optometrists. Eye doctors use the AIMS online system to drop-ship complete orders with prescription from a catalog of more than 100,000 frames from leading manufacturers.


AIMS Version 2 Next-Day Eyewear for Eye Docs
AIMS Version 2 brings the power of the internet and RFID to independent eye doctors with next-day prescription-filled glasses.

DALLAS, January 26, 2023 (Newswire.com) - SimplyRFiD, in partnership with Frame Source Group, released AIMS version 2. Launched on Jan. 23, 2023, AIMS v2 brings the latest in RFID inventory, order management, and next-day service to patients expecting fast service for eyewear.

Traditionally, optometrist offices stock 1,000 to 3,000 unique frames. Customers select a frame and that frame is sent to a lab for prescription lenses. 

Replacement frames must be re-ordered manually from a manufacturer. This process removes the 'best frame' for 2-4 weeks. Additionally, customers wait for up to two weeks while the frame goes from the doctor to a lab for processing.

"Ever wonder why the frame you want or saw on a celebrity isn't there? Because 'best sellers' only last on the board for one day!" said Greg Smith, head of sales for Frame Source. "With AIMS, the best sellers go back on the board, and AIMS handles ordering a fresh frame directly from the manufacturer. With AIMS, the best frames are always in stock."

AIMS is directly integrated with 17 manufacturers sending stock levels and providing online ordering and drop shipping for optometrists. 

Integrated Manufacturers:

  • A&A *
  • Charmant *
  • Design Eyewear  
  • Eight to Eighty Eyewear *
  • Europa *
  • Iconyx *
  • Kenmark * 
  • L'Amy *
  • Luxottica 
  • Match Eyewear *
  • Modern Optical *
  • MODO *
  • Mondottica *
  • Morel *
  • Riserva/FSD *
  • Tura * 
  • WestGroupe *

* offer same-day shipping on all frame orders and more are expected to be ready shortly. 

These manufacturers represent the top brands with more than 100,000 frame choices between them. Sample brands include Ann Taylor, Burberry, Chanel, Dolce, Oakley, Persol, Ralph Lauren, Ray-Ban, Riserva, SuperFlex and hundreds more.

AIMS v2 gives independent eye doctors the ability to compete with online retailers by offering in-person try-ons, fast delivery, and a huge selection. 

New in V2:

  • Direct order: New frames/lenses come from the manufacturer, allowing doctors to sell the best frame several times a day, increasing customers' satisfaction that the product they want is in stock.
  • Velocity Reports: Sell-through reports show which frames sell the fastest with the best margins. Low-selling products can be adjusted using frame allocation.
  • Frame Allocation and Board Management: Doctors can set levels by vendor to ensure vendors are keeping the top sellers available to their customers.
  • Cost Management: Frames are ordered as they are sold. No more bulk deliveries of 100 'new frames' that no one remembers ordering.

AIMS v2 is an extension of SimplyRFiD's #1 Wave RFID Retail Inventory system and developed in partnership since 2020.

AIMS v2 is available now from Frame Source Group at www.framesourcegroup.com. Systems start at $3,000.

Contact Information:
William Montalbo
Vice President, Marketing
[email protected]
+1 703.343.1689


Original Source: AIMS 2.0 Uses RFID to Bring Next-Day Eyewear Delivery to Independent Eye Doctors

More Than 600 Workplaces Recognized as Best Workplaces for Commuters

By
NT Editor
-
0
More Than 600 Workplaces Recognized as Best Workplaces for Commuters
2023 List Breaks All-Time Record


2023 Best Workplaces for Commuters
2023 Best Workplaces for Commuters logo

TAMPA, Fla., January 26, 2023 (Newswire.com) - Announcing the 2023 Best Workplaces for Commuters (BWC) annual list of U.S.-based employers, universities and sites that meet the program's National Standard of Excellence by providing exceptional commuter benefits and collectively changing how more than two million employees and students commute to and from work each day.

2023 Best Workplaces for Commuters list: www.bestworkplaces.org

More than 600 workplaces have been named to the 2023 Best Workplaces for Commuters list, a record-breaking year for the organization. The list includes Best Workplaces, Best Universities and Best Sites for Commuters across the U.S. continuing to provide high-level commuter benefits. 

"This year we are excited to announce a record-breaking list of workplaces," said Julie Bond, Program Manager for Best Workplaces for Commuters. "Employers that make this list demonstrate an exemplary commitment to their employees, offering commute programs, like telework, discounted transit passes, and bicycle-friendly amenities, that empower their employees to be successful at work while also supporting their individual needs."

This year, BWC announced the new 2023 "Commuter Benefits Guide for Employer Fringe Benefits." Commuter benefits encourage American workers to get to and from work in ways that reduce air pollution, improve public health, increase worker productivity, and reduce expenses and taxes for employers and employees. BWC also recognizes telework as a key benefit of a successful employee commuter benefits package, helping increase program adoption nationally. 

To receive the designation, employers submit an application to demonstrate they promote transportation choices for employees that meet the BWC National Standard of Excellence. BWC members receive national recognition and access to an array of support services to strengthen their commuter programs, including webinars, benchmark surveys, guidebooks, and peer-to-peer networking opportunities. BWC also provides tools to help workplaces assess how commuter programs benefit their organizations, their employees, and the environment.

About Best Workplaces for Commuters

Best Workplaces for Commuters (BWC) is the national authority on recognizing and assisting workplaces that provide exceptional commuter benefits to employees. More than a recognition program, BWC provides the necessary assistance to create and sustain employer-provided commuter benefit programs, and offers recognition and tailored support for employers, universities, and sites. The program is hosted by the National Institute for Congestion Relief (NICR) at the University of South Florida with support from the Florida Department of Transportation. For more information, contact [email protected] or visit www.bestworkplaces.org. #BWC2023

Contact Information:
Julie Bond
Program Manager
[email protected]
813-974-9799


Original Source: More Than 600 Workplaces Recognized as Best Workplaces for Commuters

McBee® Advises Revelstoke-Backed The Care Team on the Acquisition of 1st Care Home Health and Care Hospice

By
NT Editor
-
0
McBee® Advises Revelstoke-Backed The Care Team on the Acquisition of 1st Care Home Health and Care Hospice

WAYNE, Pa., January 26, 2023 (Newswire.com) - McBee®, an industry-leading healthcare services and consulting firm, advised The Care Team (TCT) on the acquisition of 1st Care Home Health and Care Hospice (1st Care). 

TCT, a portfolio company of Denver-based private equity firm Revelstoke Capital Partners (Revelstoke), provides hospice, home healthcare including skilled nursing, rehabilitation and therapy services, as well as social workers to patients and families operating across Michigan, Pennsylvania, Texas and Massachusetts. This successful acquisition will accelerate TCT's growing footprint in the Midwest by expanding into Indiana. The addition of 1st Care aligns with the organization's growth strategy and vision for providing high-quality home care and hospice offerings to its clients.

"We are pleased to partner with the McBee M&A Advisory team as their expertise and industry knowledge continues to guide our strategy as we scale and expand TCT into new states," said Revelstoke Vice President Jonny Miller. "McBee's consulting experts provided us with the insight and data we needed for a successful transaction, and we are pleased to have partnered with McBee on this process."

TCT and Revelstoke engaged McBee for the buy-side clinical due diligence for this transaction, which is TCT's fourth add-on acquisition since partnering with Revelstoke in 2019; McBee provided clinical due diligence support on all four deals. McBee's mergers & acquisition advisory approach included reviewing clinical documentation, compliance, and operational processes to identify potential risk and confirm that 1st Care met certain regulatory requirements. During the 2022 calendar year, McBee supported clients in completing 28 publicly reported healthcare transactions.

"We would like to congratulate TCT and Revelstoke on their transaction as they continue to expand their footprint," said McBee President Mike Dordick. "Our years of experience and  knowledge of regulatory compliance have positioned McBee as a market leader within healthcare M&A as well as enabled us to advise TCT and Revelstoke on this strategic deal."  

About The Care Team 
The Care Team offers a full spectrum of hospice care and home health services. TCT's hospice team provides specialized care in Michigan, Pennsylvania, Texas and Massachusetts that addresses the patient's physical, emotional, social, and spiritual needs while providing reprieve and comfort for patients' families. TCT Home Health employs experienced industry professionals, including physical therapists, skilled nurses, medical social workers, home health aides, and occupational and speech therapists. For more information, visit www.tctcares.com.

About Revelstoke

Revelstoke (www.revelstokecapital.com) is a private equity firm formed by experienced investors who focus on building industry-leading companies in the healthcare and related business services sectors. Revelstoke partners with entrepreneurs and management teams to execute on a disciplined organic and acquisition growth strategy as it strives to build exceptional companies. Revelstoke is based in Denver, Colorado, and has approximately $5.3 billion of assets under management. Since the firm's inception in 2013, Revelstoke has completed 173 acquisitions, which include 26 platform companies and 147 add-on acquisitions. 

About McBee
McBee® is a recognized leader in providing financial, clinical, and operational strategic advisory services that have addressed the unique needs of more than 3,800 providers across the healthcare industry. Since 1973, McBee has designed services to address challenges and ensure the success of healthcare organizations across the continuum of care by delivering meaningful insights, tailored strategies, and sustainable results. With an average of over 20 years of experience, McBee's consulting professionals have extensive expertise and in-depth knowledge of healthcare regulations and policies. Learn why health systems, physician groups, home health, hospice, long-term care, skilled nursing and other organizations look to McBee for comprehensive healthcare consulting services. 

Contact Information:
Vince Koehler
McBee Media Contact
[email protected]
9132722235

Ashley Kuhn
McBee Media Contact
[email protected]
4847340231


Original Source: McBee® Advises Revelstoke-Backed The Care Team on the Acquisition of 1st Care Home Health and Care Hospice
1...432433434...579Page 433 of 579
© Newsmag WordPress Theme by TagDiv